GRINA

gene
On this page

Also known as HNRGWTMBIM3LFG1

Summary

GRINA (glutamate ionotropic receptor NMDA type subunit associated protein 1, HGNC:4589) is a protein-coding gene on chromosome 8q24.3, encoding Protein lifeguard 1 (Q7Z429). Potential apoptotic regulator.

Predicted to enable calcium channel activity. Predicted to be involved in apoptotic signaling pathway; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; and negative regulation of neuron apoptotic process. Predicted to act upstream of or within endoplasmic reticulum calcium ion homeostasis and negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. Located in Golgi membrane.

Source: NCBI Gene 2907 — RefSeq curated summary.

At a glance

  • GWAS associations: 7
  • Clinical variants (ClinVar): 56 total
  • MANE Select transcript: NM_001009184

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4589
Approved symbolGRINA
Nameglutamate ionotropic receptor NMDA type subunit associated protein 1
Location8q24.3
Locus typegene with protein product
StatusApproved
AliasesHNRGW, TMBIM3, LFG1
Ensembl geneENSG00000178719
Ensembl biotypeprotein_coding
OMIM138251
Entrez2907

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 19 protein_coding, 3 retained_intron

ENST00000313269, ENST00000395068, ENST00000525513, ENST00000527194, ENST00000529301, ENST00000530898, ENST00000531992, ENST00000533044, ENST00000533377, ENST00000534791, ENST00000857578, ENST00000857579, ENST00000857580, ENST00000857581, ENST00000857582, ENST00000857583, ENST00000857584, ENST00000857585, ENST00000857586, ENST00000857587, ENST00000857588, ENST00000857589

RefSeq mRNA: 2 — MANE Select: NM_001009184 NM_000837, NM_001009184

CCDS: CCDS34961

Canonical transcript exons

ENST00000395068 — 7 exons

ExonStartEnd
ENSE00001319675143991878143992078
ENSE00001320349143991692143991804
ENSE00001423424143991200143991602
ENSE00001432342143992692143993415
ENSE00001520480143990056143990199
ENSE00003460558143992465143992608
ENSE00003790476143992245143992373

Expression profiles

Bgee: expression breadth ubiquitous, 281 present calls, max score 99.48.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 354.9275 / max 3901.4089, expressed in 1829 samples.

FANTOM5 promoters (16 alternative TSS)

Promoter IDTPM avgSamples expressed
91438236.89181829
9143771.01321826
9144014.49101753
9143912.71231761
914455.23561487
914432.67911286
914462.53031272
914421.8741901
914491.8410987
914441.5698785

Top tissues by expression

298 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453399.48gold quality
right testisUBERON:000453499.47gold quality
right hemisphere of cerebellumUBERON:001489099.44gold quality
stromal cell of endometriumCL:000225599.40gold quality
cerebellar hemisphereUBERON:000224599.28gold quality
right frontal lobeUBERON:000281099.25gold quality
cerebellar cortexUBERON:000212999.23gold quality
right lobe of liverUBERON:000111499.08gold quality
right adrenal gland cortexUBERON:003582799.06gold quality
right lobe of thyroid glandUBERON:000111999.02gold quality
left adrenal glandUBERON:000123499.02gold quality
left lobe of thyroid glandUBERON:000112099.01gold quality
left adrenal gland cortexUBERON:003582599.00gold quality
right adrenal glandUBERON:000123398.99gold quality
metanephros cortexUBERON:001053398.95gold quality
right lungUBERON:000216798.94gold quality
upper lobe of left lungUBERON:000895298.93gold quality
endocervixUBERON:000045898.89gold quality
omental fat padUBERON:001041498.89gold quality
peritoneumUBERON:000235898.86gold quality
mucosa of stomachUBERON:000119998.85gold quality
cortical plateUBERON:000534398.84gold quality
right ovaryUBERON:000211898.69gold quality
left uterine tubeUBERON:000130398.67gold quality
right uterine tubeUBERON:000130298.61gold quality
adenohypophysisUBERON:000219698.61gold quality
ectocervixUBERON:001224998.59gold quality
skin of legUBERON:000151198.58gold quality
esophagogastric junction muscularis propriaUBERON:003584198.58gold quality
nucleus accumbensUBERON:000188298.57gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-CURD-122yes69.76
E-ANND-3yes20.37
E-HCAD-13yes11.59
E-CURD-112no2.58

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

29 targeting GRINA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-493-5P99.9672.472382
HSA-MIR-6499-3P99.9066.381212
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-449299.8768.253611
HSA-MIR-477999.8666.501583
HSA-MIR-3177-5P99.6570.381174
HSA-MIR-76299.5866.611994
HSA-MIR-17-3P99.5566.771311
HSA-MIR-443799.5265.291266
HSA-MIR-449899.4767.422360
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-429299.1665.571767
HSA-MIR-6791-5P99.1665.921844
HSA-MIR-6868-5P99.0665.691284
HSA-MIR-5001-5P99.0566.761972
HSA-MIR-5088-5P97.9764.28487
HSA-MIR-10526-3P97.8664.971342
HSA-MIR-4723-3P97.6765.911017
HSA-MIR-9851-5P97.5767.491067
HSA-MIR-6769B-3P97.4165.531036
HSA-MIR-318397.4065.68978
HSA-MIR-6859-3P97.2664.69428
HSA-MIR-6869-5P97.1767.06634
HSA-MIR-6762-5P96.5564.62972
HSA-MIR-6845-5P96.5564.65969
HSA-MIR-56495.8565.01163
HSA-MIR-4524B-3P95.5264.12964

Literature-anchored findings (GeneRIF, showing 10)

  • The tmbim3 may participate in cell death regulation by interacting with proteins of Bcl-2 family, promoting tumor metastasis, which is deduced from the evolutionary conservation of the membrane protein family containing multiple membrane spanning segments (PMID:18440869)
  • Data showed that GRINA-C was associated with Gb3 synthase, and may demonstrate a new type of posttranscriptional regulation of glycosyltransferases. (PMID:20837469)
  • The role of TMBIM3/GRINA in the control of cell death in cellular and animal models of ER stress possibly owing to the regulation of ER calcium homeostasis. (PMID:22240901)
  • These results suggest that the TMBIM family has comparable functions in the maintenance of intracellular Ca(2) homeostasis in a wide variety of tissues (PMID:25764978)
  • Extraintestinal manifestations of celiac disease are explained on the basis of 33-mer gliadin binding to glutamate receptor GRINA. (PMID:26990286)
  • Human gastric cancers have increased levels of GRINA, which promotes growth of gastric cancer and inhibits tumor cells apoptosis. (PMID:30541591)
  • PLEC encodes plectin, a cytoskeletal protein that maintains tissue integrity. GRINA encodes TMBIM3, which regulates cell survival. We hypothesized that in a joint predisposed to Osteoarthritis (OA), expression of these genes alters to combat aberrant biomechanics and is epigenetically regulated. However, carriage of the OA risk-conferring allele at this locus hinders this response and contributes to disease development. (PMID:30730609)
  • The cytoplasmic N-terminal half of GRINA (which spans a Proline-rich domain) contains a potential DNA-binding sequence, in addition to cleavage target sites and probable PY-nuclear localization sequences, that may enable it to be released from the rest of the protein and enter the nucleus under suitable conditions, where it could participate in the transcription, alternative splicing, and mRNA export. [review] (PMID:31426446)
  • Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1, a potential target of miR-296, facilitates proliferation and migration of rectal cancer cells. (PMID:32657216)
  • Glutamate receptor, ionotropic, Nmethyl Daspartateassociated protein 1 promotes colorectal cancer cell proliferation and metastasis, and is negatively regulated by miR2963p. (PMID:34368871)

Cross-species orthologs

10 orthologs

OrganismSymbolGene ID
danio_reriogrinaaENSDARG00000101317
mus_musculusGrinaENSMUSG00000022564
rattus_norvegicusGrinaENSRNOG00000029941
drosophila_melanogasterNmda1FBGN0013305
drosophila_melanogasterLfgFBGN0025692
drosophila_melanogasterRecs1FBGN0038209
drosophila_melanogasterCG30379FBGN0050379
caenorhabditis_elegansWBGENE00006470
caenorhabditis_elegansWBGENE00009580
caenorhabditis_elegansWBGENE00021537

Paralogs (5): FAIM2 (ENSG00000135472), TMBIM1 (ENSG00000135926), TMBIM6 (ENSG00000139644), TMBIM4 (ENSG00000155957), GHITM (ENSG00000165678)

Protein

Protein identifiers

Protein lifeguard 1Q7Z429 (reviewed: Q7Z429)

Alternative names: Glutamate [NMDA] receptor-associated protein 1, NMDA receptor glutamate-binding subunit, Putative MAPK-activating protein PM02, Transmembrane BAX inhibitor motif-containing protein 3

All UniProt accessions (6): Q7Z429, E9PPG3, E9PQF8, H0YC98, H0YCP9, H0YEI4

UniProt curated annotations — full annotation on UniProt →

Function. Potential apoptotic regulator.

Subcellular location. Membrane.

Similarity. Belongs to the BI1 family. LFG subfamily.

RefSeq proteins (2): NP_000828, NP_001009184* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006214Bax_inhibitor_1-relatedFamily

Pfam: PF01027

UniProt features (16 total): transmembrane region 7, compositionally biased region 3, sequence conflict 3, chain 1, sequence variant 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z429-F171.690.40

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 232 (showing top): GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS, MODY_HIPPOCAMPUS_POSTNATAL, MORF_RAB5A, XU_GH1_AUTOCRINE_TARGETS_UP, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, PATIL_LIVER_CANCER, GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY

GO Biological Process (6): endoplasmic reticulum calcium ion homeostasis (GO:0032469), negative regulation of neuron apoptotic process (GO:0043524), apoptotic signaling pathway (GO:0097190), negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042), negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236), calcium ion transmembrane transport (GO:0070588)

GO Molecular Function (3): calcium channel activity (GO:0005262), transmembrane transporter binding (GO:0044325), protein binding (GO:0005515)

GO Cellular Component (4): Golgi membrane (GO:0000139), endoplasmic reticulum (GO:0005783), Golgi apparatus (GO:0005794), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm2
endomembrane system2
intracellular membrane-bounded organelle2
endoplasmic reticulum1
intracellular calcium ion homeostasis1
negative regulation of apoptotic process1
regulation of neuron apoptotic process1
neuron apoptotic process1
apoptotic process1
signal transduction1
extrinsic apoptotic signaling pathway via death domain receptors1
regulation of extrinsic apoptotic signaling pathway via death domain receptors1
negative regulation of extrinsic apoptotic signaling pathway1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress1
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway1
negative regulation of response to endoplasmic reticulum stress1
negative regulation of intrinsic apoptotic signaling pathway1
calcium ion transport1
monoatomic cation transmembrane transport1
monoatomic cation channel activity1
calcium ion transmembrane transporter activity1
protein binding1
binding1
Golgi apparatus1
bounding membrane of organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

1044 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GRINATGP01266691
GRINATMBIM6P55061688
GRINAGRIN2DO15399629
GRINAPARP10Q53GL7593
GRINAGHITMQ9H3K2591
GRINATMEM276P0DTL5519
GRINAPLECQ15149509
GRINAITPR3Q14573506
GRINAITPR1Q14643504
GRINAGRIK4Q16099499
GRINAPDCD6O75340479
GRINACALML5Q9NZT1469
GRINACALML3P27482460
GRINAARHGAP39Q9C0H5460
GRINAMROH1Q8NDA8455

IntAct

26 interactions, top by confidence:

ABTypeScore
GRINAGPX8psi-mi:“MI:0915”(physical association)0.560
TIAL1GRINApsi-mi:“MI:0915”(physical association)0.560
KRTAP19-5GRINApsi-mi:“MI:0915”(physical association)0.560
GGT6GRINApsi-mi:“MI:0915”(physical association)0.560
KRTAP6-2GRINApsi-mi:“MI:0915”(physical association)0.560
FMO1GRINApsi-mi:“MI:0915”(physical association)0.560
GRINATMEM242psi-mi:“MI:0915”(physical association)0.560
GRINADRD2psi-mi:“MI:0915”(physical association)0.370
GRINAGAMMAHV.M3psi-mi:“MI:0915”(physical association)0.370
TIAL1GRINApsi-mi:“MI:0915”(physical association)0.000
GRINAKRTAP6-2psi-mi:“MI:0915”(physical association)0.000
GRINAFMO1psi-mi:“MI:0915”(physical association)0.000
GRINAKRTAP19-5psi-mi:“MI:0915”(physical association)0.000
GRINAGGT6psi-mi:“MI:0915”(physical association)0.000
GRINATMEM242psi-mi:“MI:0915”(physical association)0.000
GRINApsi-mi:“MI:0915”(physical association)0.000
ald1GRINApsi-mi:“MI:0915”(physical association)0.000

BioGRID (12): GRINA (PCA), GRINA (Affinity Capture-MS), GRINA (Two-hybrid), GRINA (Two-hybrid), GRINA (Two-hybrid), GRINA (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP19-5 (Two-hybrid), TMEM242 (Two-hybrid), GRINA (Two-hybrid), GRINA (Proximity Label-MS), GRINA (Affinity Capture-RNA)

ESM2 similar proteins: A1KXE4, A8E639, D4AEP3, O95415, P0C0T0, P28662, P56603, P60486, P97765, Q0VFP2, Q15038, Q32L53, Q32L83, Q3SZ48, Q3T0K9, Q4R5H7, Q4V888, Q58D45, Q5BJ83, Q5EAU3, Q5HZN7, Q5PPK1, Q5R4K6, Q5R526, Q5RDV6, Q5U2U6, Q5XIH2, Q5ZIS9, Q6GMG8, Q6P6R0, Q6P828, Q7Z429, Q80XQ8, Q8AVW3, Q8CA71, Q8N114, Q8N4L2, Q8QGW7, Q8R478, Q969T9

Diamond homologs: F4JIE8, O25578, O31539, O74888, O88407, P0DXN1, P0DXN2, P0DXN3, Q11080, Q1LZ71, Q32L53, Q5R4I4, Q6P6R0, Q7Z429, Q8K097, Q94A20, Q9BWQ8, Q9DA39, Q9ESF4, Q9HC24, Q9KSA1, Q9M1V9, Q9PIQ8, Q9SA63, Q9ZKT1, Q9ZQX7, Q8BJZ3, Q969X1, Q9A2A3, P0AAC4, P0AAC5, P48558, Q5R7R1, Q03268, Q9CEU8, P55061

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

56 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance42
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1036 predictions. Top by Δscore:

VariantEffectΔscore
8:143991690:A:AGacceptor_gain1.0000
8:143991691:G:GAacceptor_gain1.0000
8:143991691:GC:Gacceptor_gain1.0000
8:143991691:GCA:Gacceptor_gain1.0000
8:143991691:GCAC:Gacceptor_gain1.0000
8:143991691:GCACC:Gacceptor_gain1.0000
8:143991800:GCAAG:Gdonor_gain1.0000
8:143991801:CAAG:Cdonor_loss1.0000
8:143991805:G:GGdonor_gain1.0000
8:143991806:T:Adonor_loss1.0000
8:143992240:T:Aacceptor_gain1.0000
8:143992240:TGCAG:Tacceptor_loss1.0000
8:143992241:GCA:Gacceptor_loss1.0000
8:143992242:CAGTC:Cacceptor_loss1.0000
8:143992243:A:AGacceptor_gain1.0000
8:143992243:AGTC:Aacceptor_gain1.0000
8:143992244:G:GAacceptor_gain1.0000
8:143992244:GT:Gacceptor_gain1.0000
8:143992244:GTC:Gacceptor_gain1.0000
8:143992244:GTCG:Gacceptor_gain1.0000
8:143992273:T:TAacceptor_gain1.0000
8:143992370:GCAG:Gdonor_gain1.0000
8:143992374:G:GAdonor_loss1.0000
8:143992375:T:Gdonor_loss1.0000
8:143992457:A:AGacceptor_gain1.0000
8:143992460:TGCAG:Tacceptor_loss1.0000
8:143992461:GCAGA:Gacceptor_loss1.0000
8:143992462:CAGA:Cacceptor_loss1.0000
8:143992463:A:ACacceptor_loss1.0000
8:143992463:A:AGacceptor_gain1.0000

AlphaMissense

2396 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:143991793:T:CF161L1.000
8:143991795:C:AF161L1.000
8:143991795:C:GF161L1.000
8:143991903:T:CL173P1.000
8:143992279:G:AG243E1.000
8:143992344:T:CC265R1.000
8:143992589:G:AG316D1.000
8:143991785:G:CR158P0.999
8:143991794:T:CF161S0.999
8:143991891:T:CL169P0.999
8:143991963:T:AV193D0.999
8:143992050:G:CR222P0.999
8:143992077:T:CL231P0.999
8:143992260:A:CS237R0.999
8:143992262:C:AS237R0.999
8:143992262:C:GS237R0.999
8:143992278:G:AG243R0.999
8:143992278:G:CG243R0.999
8:143992278:G:TG243W0.999
8:143992288:C:AA246D0.999
8:143992320:G:CA257P0.999
8:143992354:T:AV268D0.999
8:143992478:T:CF279S0.999
8:143992507:A:CS289R0.999
8:143992509:C:AS289R0.999
8:143992509:C:GS289R0.999
8:143992588:G:CG316R0.999
8:143992606:T:CC322R0.999
8:143992696:T:AL324H0.999
8:143992696:T:CL324P0.999

dbSNP variants (sampled 300 via entrez): RS1000602570 (8:143990929 A>G), RS1001264450 (8:143993141 G>A,T), RS1002271584 (8:143992192 A>C), RS1002850287 (8:143988529 G>A), RS1003404964 (8:143988715 G>A), RS1004071190 (8:143991936 C>G,T), RS1004523603 (8:143989938 T>C), RS1005741134 (8:143992953 A>G), RS1007691459 (8:143988398 C>T), RS1008381165 (8:143991572 C>T), RS1008953418 (8:143989878 G>C), RS1009755776 (8:143992454 C>T), RS1011380913 (8:143993198 C>T), RS1011915810 (8:143990894 G>C), RS1012443478 (8:143990654 G>A,C)

Disease associations

OMIM: gene MIM:138251 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST002898_12LDL cholesterol2.000000e-10
GCST004121_35Fibrinogen levels5.000000e-08
GCST005993_43Mean corpuscular hemoglobin2.000000e-09
GCST006011_75Mean corpuscular volume1.000000e-08
GCST008103_86Bipolar disorder1.000000e-06
GCST008115_8Bipolar I disorder2.000000e-08
GCST010703_132Brain morphology (MOSTest)3.000000e-08

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004611low density lipoprotein cholesterol measurement
EFO:0004527mean corpuscular hemoglobin
EFO:0009963bipolar I disorder
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

43 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases abundance, increases expression, decreases expression, affects cotreatment3
Benzo(a)pyrenedecreases expression, increases methylation3
Valproic Acidaffects cotreatment, decreases expression3
bisphenol Aaffects expression, decreases methylation2
tamibaroteneaffects expression, increases expression2
Air Pollutantsincreases abundance, increases expression, decreases expression2
Arsenicaffects cotreatment, increases abundance, increases expression, decreases expression2
Tretinoindecreases expression, increases expression2
Particulate Matterdecreases expression, increases abundance, increases expression2
aristolochic acid Iincreases expression1
bisphenol Faffects cotreatment, increases expression1
alpha phellandreneincreases expression1
triphenyl phosphateaffects expression1
manganese chlorideincreases expression, affects cotreatment, increases abundance1
cupric chloridedecreases expression1
perfluorodecanoic aciddecreases expression1
pinostrobinincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, decreases expression1
MT19c compounddecreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Resveratrolincreases expression1
Sunitinibincreases expression1
Fulvestrantincreases methylation1
Acetaminophenincreases expression1
Atrazineincreases expression1
Cisplatindecreases expression1
Dexamethasoneaffects cotreatment, increases expression1
Diethylstilbestrolincreases expression1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_SQ53HAP1 GRINA (-) 1Cancer cell lineMale
CVCL_XP37HAP1 GRINA (-) 2Cancer cell lineMale
CVCL_XP38HAP1 GRINA (-) 3Cancer cell lineMale
CVCL_XP39HAP1 GRINA (-) 4Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.